Global Organoids Market Size, Status and Forecast 2021-2027

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.
North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.
Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.

Market Analysis and Insights: Global Organoids Market
The global Organoids market size is projected to reach US$ 241.3 million by 2027, from US$ 74 million in 2020, at a CAGR of 18.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Organoids market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Organoids market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Organoids market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Organoids market.

Global Organoids Scope and Market Size
Organoids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organoids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
3D Organoid Culture
Biochemical Cues

Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero

Frequently Asked Questions